Literature DB >> 11914622

Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.

Laila El-Shabrawi-Caelen1, Lorenzo Cerroni, L Jeffrey Medeiros, Timothy H McCalmont.   

Abstract

Hypopigmented mycosis fungoides (MF) is a form of cutaneous T-cell lymphoma in which hypopigmentation occurs in the absence of classic lesions of MF. Hypopigmented MF predominantly affects people with dark complexions. The natural history of this variant of cutaneous T-cell lymphoma is similar to that of conventional MF, although the disease onset is usually in childhood or adolescence. In a retrospective study we evaluated the clinical, histopathologic, immunohistochemical, and molecular characteristics of hypopigmented MF in 15 patients. Similar to other reports, the disease onset occurred in childhood and adolescence in most of the cases. The survival rate was comparable with that of classic MF. We did not observe progression to systemic disease or lymph node involvement. Histopathologically hypopigmented lesions were indistinguishable from hyperpigmented or erythematous patches. On immunohistochemical analysis a predominantly CD8+ infiltrate was detected in the majority of cases (nine of 15 patients). To determine whether epidermotropic CD8+ T cells represent the malignant T-cell clone or whether these cells are innocent, tumor-infiltrating T lymphocytes, we performed microdissection of epidermotropic CD8+ T cells and analyzed T-cell receptor-gamma chain gene for rearrangements. The epidermotropic CD8+ T lymphocytes showed clonal T-cell receptor gene rearrangement and therefore represented the malignant T-cell clone. We conclude that hypopigmented MF tends to occur in young people and that it belongs to the group of CD8+ cutaneous T-cell lymphomas in the majority of cases.

Entities:  

Mesh:

Year:  2002        PMID: 11914622     DOI: 10.1097/00000478-200204000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Hypopigmented Mycosis Fungoides: A Clinicopathological Review of 32 Patients.

Authors:  Hao-Ze Shi; Yi-Qun Jiang; Xiu-Lian Xu; Wei Zhang; Hao Song; Xiao-Po Wang; Xue-Si Zeng; Jian-Fang Sun; Hao Chen
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-04

2.  Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.

Authors:  Shamir Geller; Emily Lebowitz; Melissa P Pulitzer; Steven M Horwitz; Alison J Moskowitz; Steve Dusza; Patricia L Myskowski
Journal:  J Am Acad Dermatol       Date:  2019-09-06       Impact factor: 11.527

Review 3.  Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.

Authors:  Thamy Yamashita; Luciana Patricia Fernandes Abbade; Mariangela Esther Alencar Marques; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

4.  Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.

Authors:  Oun Jae Park; Ji Su Han; Sang Hyung Lee; Chan-Sik Park; Chong Hyun Won; Mi Woo Lee; Jee Ho Choi; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

5.  Origin Use of CD4, CD8, and CD1a Immunostains in Distinguishing Mycosis Fungoides from its Inflammatory Mimics: A Pilot Study.

Authors:  Rajalakshmi Tirumalae; Poonam K Panjwani
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

6.  Hypopigmented mycosis fungoides in type v skin: a report of 5 cases.

Authors:  Ranthilaka R Ranawaka; Priyanka H Abeygunasekara; M V Chandu de Silva
Journal:  Case Rep Dermatol Med       Date:  2011-12-20

Review 7.  Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology.

Authors:  Fabricio Cecanho Furlan; José Antonio Sanches
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.